US pharmaceutical companies based in Ireland are more likely to shift profits back to the US than close manufacturing plants after Donald Trump accused Ireland of stealing American tax and jobs, experts say.
Aidan Regan, a professor of political economy at University College Dublin, said the US president was right to call out the trade imbalance created by US pharmaceutical companies in Ireland, arguing the warning signs have been there for years.
